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Monoclonal Antibodies in Cancer. Edited by S. SELL
& R. REISFELD CLIFTON. Humana Press, xvii+428
pp, 1985, £68. ISBN 0 89603 068 7.
This multi-author book concerns the applications of
monoclonal antibodies in the study, diagnosis and
treatment of cancer. It represents the third volume
in a series on cancer markers and updates the vast
amount of information that is accumulating on the
use of monoclonal antibodies in the identification
of cancer antigens. The first chapter deals with a
brief review on the use of monoclonal antibodies in
the study of antigens associated with experimental
animal tumours with emphasis on areas of research
where these reagents have proven or potential
usage. The following chapters concentrate on the
human system and focus on individual human
tumour types, hormones, major histocompatibility,
complex antigens and oncofetal antigens. The
chapter on monoclonal carcinoembryonic antigen
(CEA) antibodies reviews the use of antibodies in
understanding the immunobiology of CEA and also
discusses how CEA antibodies can be used in
immunohistological diagnosis, tumour imaging and
immunotherapy. A chapter on melanoma describes
how monoclonal antibodies can be used as probes
for the molecular structure and biological function
ofmelanoma-associated antigens. These applications
of monoclonal antibodies in the molecular charac-
terisation of tumour antigens, in diagnosis and their
present status in cancer therapy are emphasized
throughout the remaining chapters. The relative
values of monoclonal versus polyclonal antibodies
are discussed. Problems associated with antigenic
heterogeneity and the use of antibody panels or
mixtures are also discussed. Review chapters cover
a range of tumour and cell types, including lung,
breast, kidney, prostate, brain tumours, T and B
cells and myeloid leukemia. The chapter on major
histocompatibility complex (MHC) antigens on
tumour cells focuses on the possible relationship
of expression of MHC antigens and neoplasia and
the potential involvement of these membrane glyco-
proteins in host-tumour reactions. Most of the
information reviewed relates to the murine system
but the potential relevance of the findings to human
tumour immunology is discussed. The last chapter
in the book is on human-human hybridomas and
discusses their potential application in defining the
humoral immune response of patients with cancer.
Although this book is more orientated towards
research workers, the clinical application of
monoclonal antibodies is well documented and it
contains useful information of value to all those
working in the field of tumour markers.
A.K. Ghosh
Precancerous Lesions of the Gastrointestinal Tract:
A Histological Classification. By: B.C. MORSON,
J.R. JASS & L.H. SOBIN. Bailliere Tindall, vii+175
pp, 1985, £22.50. ISBN 0 7020 1053 7.
Although this handbook is meant for the
histopathology reporting room, it can be strongly
recommended to the biologist in cancer research as
a source book, for two purposes: to illustrate how
pathologists work and to alert the biologist to
structural nuances in neoplasia.
The team from St Marks, commissioned by
WHO, write with authority with the specific object
of illustrating precancerous lesions of the
gastrointestinal tract to standardise nomenclature.
A few pages of text classify and describe the
lesions, but the 149 excellent, comparable
photomicrographs provide the substance. At this
price, it will be widely used.
If our biologist thought that precancerous
epithelial lesions took one or two forms, he should
study the book carefully with a sympathetic
pathologist on hand to translate the jargon. As it
makes no claim to discuss the lesions fully,
widespread assumptions will be revealed.
Curiously no definition of cancer is given
although this would specify one limit to the subject
under study. The authors launch straight into the
description. This is classical histopathology: the
structure of the biopsy is carefully assessed, and
then compared with biopsies (or their descriptions)
from earlier cases, whose outcome is known.
Experienced histopathologists become skilled at
foretelling the future in this way. Here the lesions
considered precancerous, collectively called
dysplasia, are shown although little is known yet of
the associated risk.
The classification by organ and pre-existing
disease might worry a biologist but suits the
pathologist. Each clinical decision is made against
its own background. But the accounts are uneven.
The cytological descriptions of dysplasia in
ulcerative colitis are very detailed (and well
illustrated) but sketchy in adenomas of the same
organ (and barely illustrated).150 BOOK REVIEWS
The biologist will be confused on the histological
threshold criteria used to diagnose malignancy in
colonic adenomas. For severe dysplasia invading
the mucosal connective tissue but not the
muscularis mucosae 'the most accurate descriptive
term is "intramucosal carcinoma"'. But 'To prevent
confusion the term "intramucosal carcinoma" is
best avoided in the colon.' The authors believe,
perhaps correctly, that metastasis of these lesions
occurs by lymphatic channels only, that there are
none in colonic mucosa and that reporting
'carcinoma' may lead to unnecessary radical
surgery. In consequence suspicious, superficially
invasive lesions will be lumped with the benign for
analysis, and possible variations in risk lost.
Two points will particularly interest those
working with human material. A single prognostic
term can cover different cytological abnormalities
(e.g. severe dysplasia in Figures 122, 128 and 132),
and carcinoma arises in other conditions, whose
cause is often unknown. Are either relevant to the
variety of oncogenes reported?
But perhaps the biologist will be most thoughtful
considering hazards in diagnosis: apparent dysplasia
or pseudoinvasion due to inflammation or
radiation. Would he make a decision with such
risks?
C. Rowlatt
Endocrine Tumours: The Pathobiology ofRegulatory
Peptide-Producing Tumours. By: J.M. POLAK &
S.R. BLOOM. Churchill Livingstone, xi+288 pp,
1985, £35.00. ISBN 0 443 02979 2.
As one who studied pathology in an era when the
glandular cells of the anterior pituitary were
traditionally divided into acidophils, basophils and
chromophobes, this book is a revelation. The
development of new techniques in cell biology -
molecular genetics, monoclonal antibodies, light
and electron microscopic immunocytochemistry, in
situ DNA hybridisation and recombinant DNA
technology have all begun to impinge on our
understanding, histopathological classification and
treatment of endocrine tumours.
Four chapters are devoted to understanding
peptide biosynthetic pathways and three chapters
on new methods of histological examination.
Excellent chapters review the use of in vitro models
for studying the pathobiology of endocrine tumours
and the potential clinical use of neuron-specific
enolase as a tumour marker.
The last third of the book contains four chapters
which consider how our perception of endocrine
tumours of the gut and pancreas, lung, medullary
carcinoma of the thyroid and pituitary adenomas
has been modified using new technology.
My only criticisms are minor. I thought the last
chapter on endocrine syndromes was out of place in
this volume and should have been omitted. In the
chapter on endocrine tumours of gut and pancreas
the authors are confused in their description of
clinical presentation of MEA type I and type II
syndromes and in the introductory chapter the
word thyroid is frequently misspelt.
This is the first volume in a series written for
pathologists. It is expensive at £35, but I would
recommend a copy be purchased by every
pathology department.
S.M. Shalet
Hormone-Producing Tumours of the Gastrointestinal
Tract - Contemporary Issues in Gastroenterology,
Vol. 5. Edited by S. COHEN & R.D. SOLOWAY.
Churchill Livingstone, ix+ 164 pp, 1985, £36.00.
ISBN 0 443 08370 3.
This book on hormone producing gastrointestinal
tumours, deals informatively with the well-
established and the newly-emerging gastrointestinal
- peptidergic - syndromes. The current diagnostic
methods and management of gastronomas is well
presented with a pragmatic approach to treatment.
The chapter on somatostatinomas draws attention
to the newly emerging syndrome associated with
this tumour, which should lead to better
recognition and earlier diagnosis of this disorder,
rather than the present situation of incidental
histological diagnosis postoperatively. The chapters
on glucagon producing tumours and VIPoma
syndrome are very comprehensive, the latter
drawing on what must be one of the largest
personal experience of such tumours. The chapter
on surgical management serves as a concise
overview and briefly discusses carcinoid tumours
and insulinomas. The first chapter gives a general
introduction and the necessary histopathological
background to the subject. It is a useful book for
endocrinologists, gastroenterologists and the
specialist surgeon, though slightly overpriced.
Syed Rafeeq Ahmed
Advances in Cancer Research, Vol. 43. Edited by G.
KLEIN & S. WEINHOUSE. Academic Press, x+320
pp, 1985, £41.00. ISBN 0 12 006643 2.
Review volumes should be up to date, although this
is less important for the non-specialists who wish to